Real-world Study of UTD1 in Chinese Advanced Breast Cancer

NCT05386511 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-02-26

No results posted yet for this study

Summary

To evaluate the efficacy and safety of UTD1 in patients with advanced breast cancer.

Conditions

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05386511 on ClinicalTrials.gov